compounding glp-1 enforcement news The FDA's Crackdown Continues: What to Know Compound versions of GLP-1 drugs

In the 6-OHDA rat model of PD, GIP showed clear neuroprotective effects [142]

Dose-by-dose weight loss in Phase 2 (NEJM) Phase 2 NEJM weight loss by dose, 24 and 48 weeks Dose 1 mg 24 weeks -7.2% 48 weeks -8.7% Dose 4 mg 24 weeks -12.9% 48 weeks -17.5% Dose 8 mg 24 weeks -15.7% 48 weeks -22.8% Dose 12 mg 24 weeks -17.5% 48 weeks -24.2% Dose Placebo 24 weeks -1.6% 48 weeks -2.1% Source: Jastreboff et al., NEJM 2023

H.HermansonD

These flavor-packed options represent convenience, comfort, and cultural connection that generic diets would eliminate completely

Increased plasma dipeptidyl peptidase-4 activities are associated with high prevalence of diabetic nephropathy in Chinese patients with newly diagnosed type 2 diabetes: a cross-sectional study

Although these digest slightly slower than whey, high-quality plant formulas can still support muscle recovery and maintenance when consumed consistently